Avi | Download Elf

Ceftazidime/Avibactam remains a cornerstone therapy for difficult-to-treat infections, particularly those involving KPC-producing strains.

: Real-world studies consistently show CAZ-AVI provides superior outcomes and reduced mortality compared to older, more toxic alternatives like colistin. In large multicenter cohorts, 28-day mortality rates for patients treated with CAZ-AVI for CRE infections were recorded as low as 20%. Download Elf avi

: For treating nosocomial pneumonia, achieving high concentrations in the ELF is vital. Systematic reviews indicate that CAZ-AVI typically achieves a Probability of Target Attainment (PTA) of in the ELF against common pathogens with MICs ≤4is less than or equal to 4 : For treating nosocomial pneumonia

: While other newer agents like Meropenem/Vaborbactam (MER-VAB) show success rates between 60% and 75%, CAZ-AVI is often preferred for its robust data set in treating KPC and OXA-48 producers. Download Elf avi